| Date Filed | Type | Description |
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
8-K
| Quarterly results |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 04/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/29/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/29/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/29/2023 |
8-K
| Quarterly results |
| 02/28/2023 |
4
| Yonehiro Grant (Chief Business Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 228,000 options to buy
@ $1.59, valued at
$362.5k
|
|
| 02/28/2023 |
4
| Schatzman Randall C (CEO) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 728,270 options to buy
@ $1.59, valued at
$1.2M
|
|
| 02/28/2023 |
4
| Perez Edith A. (Chief Medical Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $1.59, valued at
$397.5k
|
|
| 02/28/2023 |
4
| Quinn William P. (CFO) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $1.59, valued at
$397.5k
|
|
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2023 |
5
| Yonehiro Grant (Chief Business Officer) has filed a Form 5 on Bolt Biotherapeutics, Inc. |
| 02/07/2023 |
5
| Schatzman Randall C (CEO) has filed a Form 5 on Bolt Biotherapeutics, Inc. |
| 02/07/2023 |
5
| Perez Edith A. (Chief Medical Officer) has filed a Form 5 on Bolt Biotherapeutics, Inc. |
| 02/07/2023 |
5
| Quinn William P. (CFO) has filed a Form 5 on Bolt Biotherapeutics, Inc. |
| 01/04/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/28/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/14/2022 |
8-K
| Quarterly results |
| 11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/10/2022 |
8-K
| Quarterly results |
| 09/30/2022 |
SC 13D/A
| Novo Holdings A/S reports a 9.8% stake in Bolt Biotherapeutics, Inc. |
| 08/10/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/10/2022 |
8-K
| Quarterly results |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|